A novel biodegradable pancreatic stent for human pancreatic applications: a preclinical safety study in a large animal model

Gastrointestinal Endoscopy

Volumn 67, Issue 7, 2008, Pages 1106-1112

  Laukkarinen, Johanna ^a   Lämsä, Teemu ^a   Nordback, Isto ^a   Mikkonen, Joonas ^a   Sand, Juhani ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM SULFATE; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BIODEGRADABLE IMPLANT; BLOOD EXAMINATION; CONTROLLED STUDY; EUTHANASIA; FOLLOW UP; HISTOLOGY; HUMAN; NONHUMAN; PANCREAS DUCT; PANCREATIC STENT; PANCREATITIS; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STENT; VASODILATATION; WEIGHT GAIN; X RAY FILM;

ABSORBABLE IMPLANTS; ANIMALS; BIOPSY, NEEDLE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREATIC DISEASES; PANCREATIC DUCTS; PROSTHESIS DESIGN; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STENTS; SWINE;

EID: 44149103475     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2007.10.013     Document Type: Article

References (13)

1. Delhaye M., Arvanitakis M., Bali M., et al. Endoscopic therapy for chronic pancreatitis. Scand J Surg 94 (2005) 143-153
2. Parviainen M., Sand J., Harmoinen A., et al. A new biodegradable stent for the pancreaticojejunal anastomosis after pancreaticoduodenal resection: in vitro examination and pilot experiences in humans. Pancreas 21 (2000) 14-21
3. 4 containing poly-D, L-lactide) with rat pancreas. Pancreatology 6 (2006) 301-305
4. Laukkarinen J., Sand J., Chow P., et al. A novel biodegradable biliary stent in the normal duct hepaticojejunal anastomosis: an 18-month follow-up in a large animal model. J Gastrointest Surg 11 (2007) 750-757
5. Laukkarinen J., Nordback I., Mikkonen J., et al. A novel biodegradable biliary stent in the endoscopic treatment of cystic-duct leakage after cholecystectomy. Gastrointest Endosc 65 (2007) 1063-1068
6. Niederau C., Liddle R.A., Ferrell L.D., et al. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest 78 (1986) 1056-1063
7. Schmidt J., Rattner D.W., Lewandrowski K., et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg 215 (1992) 44-56
8. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 60 (2004) 544-550
9. Laukkarinen J., Sand J., Mikkonen J., et al. The treatment of a benign biliary stricture with a novel, endoscopically inserted biodegradable biliary stent. [abstract]. Gastrointest Endosc 61 (2005) AB97
10. Freeman M.L., Overby C., and Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 59 (2004) 8-14
11. Ginsberg G., Cope C., Shah J., et al. In vivo evaluation of a new bioabsorbable self-expanding biliary stent. Gastrointest Endosc 58 (2003) 777-784
12. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 57 (2003) 291-294
13. Rashdan A., Fogel E.L., McHenry Jr. L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 322-329